|
1
|
Guilbert JJ: The world health report
2002-reducing risks, promoting healthy life. Educ Health
(Abingdon). 16:2302003.
|
|
2
|
Becker LC and Ambrosio G: Myocardial
consequences of reperfusion. Prog Cardiovasc Dis. 30:23–44. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gottlieb RA and Engler RL: Apoptosis in
myocardial ischemia-reperfusion. Ann N Y Acad Sci. 874:412–426.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zweier JL and Talukder MA: The role of
oxidants and free radicals in reperfusion injury. Cardiovasc Res.
70:181–190. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Andrassy M, Volz HC, Igwe JC, Funke B,
Eichberger SN, Kaya Z, Buss S, Autschbach F, Pleger ST, Lukic IK,
et al: High-mobility Group box-1 in ischemia-reperfusion injury of
the heart. Circulation. 117:3216–3226. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hashimoto T, Ishii J, Kitagawa F, Yamada
S, Hattori K, Okumura M, Naruse H, Motoyama S, Matsui S, Tanaka I,
et al: Circulating high-mobility Group box 1 and cardiovascular
mortality in unstable angina and non-ST-segment elevation
myocardial infarction. Atherosclerosis. 221:490–495. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hu XR, Wang XH, Liu HF, Zhou WJ and Jiang
H: High mobility Group box 1 protein: Possible pathogenic link to
atrial fibrillation. Chin Med J (Engl). 125:2346–2348. 2012.
|
|
8
|
Tsung A, Sahai R, Tanaka H, Nakao A, Fink
MP, Lotze MT, Yang H, Li J, Tracey KJ, Geller DA, et al: The
nuclear factor HMGB1 mediates hepatic injury after murine liver
ischemia-reperfusion. J Exp Med. 201:1135–1143. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Eulalio A, Huntzinger E and Izaurralde E:
Getting to the root of miRNA-mediated gene silencing. Cell.
132:9–14. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Perron MP and Provost P: Protein
interactions and complexes in human microRNA biogenesis and
function. Front Biosci. 13:2537–2547. 2008. View Article : Google Scholar
|
|
12
|
Hwang HW and Mendell JT: MicroRNAs in cell
proliferation, cell death, and tumorigenesis. Br J Cancer.
94:776–780. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ren XP, Wu J, Wang X, Sartor MA, Qian J,
Jones K, Nicolaou P, Pritchard TJ and Fan GC: MicroRNA-320 is
involved in the regulation of cardiac ischemia/reperfusion injury
by targeting heat-shock protein 20. Circulation. 119:2357–2366.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Van Rooij E and Olson EN: MicroRNAs:
Powerful new regulators of heart disease and provocative
therapeutic targets. J Clin Invest. 117:2369–2376. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cheng Y, Zhu P, Yang J, Liu X, Dong S,
Wang X, Chun B, Zhuang J and Zhang C: Ischaemic
preconditioning-regulated miR-21 protects heart against
ischaemia/reperfusion injury via anti-apoptosis through its target
PDCD4. Cardiovasc Res. 87:431–439. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tang Y, Zheng J, Sun Y, Wu Z, Liu Z and
Huang G: MicroRNA-1 regulates cardiomyocyte apoptosis by targeting
Bcl-2. Int Heart J. 50:377–387. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ye Y, Hu Z, Lin Y, Zhang C and Perez-Polo
JR: Downregulation of microRNA-29 by antisense inhibitors and a
PPAR-gamma agonist protects against myocardial
ischaemia-reperfusion injury. Cardiovasc Res. 87:535–544. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang X, Wang X, Zhu H, Zhu C, Wang Y, Pu
WT, Jegga AG and Fan GC: Synergistic effects of the GATA-4-mediated
miR-144/451 cluster in protection against simulated
ischemia/reperfusion-induced cardiomyocyte death. J Mol Cell
Cardiol. 49:841–850. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. 4:2015. View Article : Google Scholar
|
|
20
|
National Research Council (US) Committee
for the Update of the Guide for the Care and Use of Laboratory
Animals: Guide for the Care and Use of Laboratory Animals. National
Academies Press (US); Washington (DC): 2011
|
|
21
|
Hu X, Zhou X, He B, Xu C, Wu L, Cui B, Wen
H, Lu Z and Jiang H: Minocycline protects against myocardial
ischemia and reperfusion injury by inhibiting high mobility Group
box 1 protein in rats. Eur J Pharmacol. 638:84–89. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
23
|
Xie J, Zhou X, Hu X and Jiang H: H2O2
evokes injury of cardiomyocytes through upregulating HMGB1.
Hellenic J Cardiol. 55:101–106. 2014.PubMed/NCBI
|
|
24
|
Bergamaschi A and Katzenellenbogen BS:
Tamoxifen downregulation of miR-451 increases 14-3-3ζ and promotes
breast cancer cell survival and endocrine resistance. Oncogene.
31:39–47. 2012. View Article : Google Scholar
|
|
25
|
Lopotová T, Záčková M, Klamová H and
Moravcová J: MicroRNA-451 in chronic myeloid leukemia:
miR-451-BCR-ABL regulatory loop? Leuk Res. 35:974–977. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yu D, dos Santos CO, Zhao G, Jiang J,
Amigo JD, Khandros E, Dore LC, Yao Y, D'Souza J, Zhang Z, et al:
miR-451 protects against erythroid oxidant stress by repressing
14-3-3zeta. Genes Dev. 24:1620–1633. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang X, Zhu H, Zhang X, Liu Y, Chen J,
Medvedovic M, Li H, Weiss MJ, Ren X and Fan GC: Loss of the
miR-144/451 cluster impairs ischaemic preconditioning-mediated
cardioprotection by targeting Rac-1. Cardiovasc Res. 94:379–390.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tsung A, Klune JR, Zhang X, Jeyabalan G,
Cao Z, Peng X, Stolz DB, Geller DA, Rosengart MR and Billiar TR:
HMGB1 release induced by liver ischemia involves Toll-like receptor
4 dependent reactive oxygen species production and calcium-mediated
signaling. J Exp Med. 204:2913–2923. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang QW, Xiang J, Zhou Y, Zhong Q and Li
JC: Targeting HMGB1/TLR4 signaling as a novel approach to treatment
of cerebral ischemia. Front Biosci (Schol Ed). 2:1081–1091. 2010.
View Article : Google Scholar
|
|
30
|
Yang Z, Deng Y, Su D, Tian J, Gao Y, He Z
and Wang X: TLR4 as receptor for HMGB1-mediated acute lung injury
after liver ischemia/reperfusion injury. Lab Invest. 93:792–800.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Andersson U, Wang H, Palmblad K, Aveberger
AC, Bloom O, Erlandsson-Harris H, Janson A, Kokkola R, Zhang M,
Yang H, et al: High mobility Group 1 protein (HMG-1) stimulates
proinflammatory cytokine synthesis in human monocytes. J Exp Med.
92:565–570. 2000. View Article : Google Scholar
|
|
32
|
Sha Y, Zmijewski J, Xu Z and Abraham E:
HMGB1 develops enhanced proinflammatory activity by binding to
cytokines. J Immunol. 180:2531–2537. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xu H, Yao Y, Su Z, Yang Y, Kao R, Martin
CM and Rui T: Endogenous HMGB1 contributes to
ischemia-reper-fusion-induced myocardial apoptosis by potentiating
the effect of TNF-α/JNK. Am J Physiol Heart Circ Physiol.
300:H913–921. 2011. View Article : Google Scholar
|
